UNSPSC 51201648: Rubella and mumps virus vaccine

This classification denotes a combination vaccine. The first component of this combination vaccine addresses that acute infectious disease caused by the rubella virus, of type species of rubivirus causing acute infection in humans, primarily children and young adults, and which enters the respiratory tract via airborne droplet and spreads to the lymphatic system.

The second component of this combination vaccine addresses an acute infectious disease caused by rubulavirus (a genus of the family paramyxoviridae and subfamily paramyxovirinae, where all the species have hemagglutinin and neuraminidase activities but lack a C protein), which is spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected.

UNSPSC 51201648 Rubella and mumps virus vaccine is a Commodity code that state and local health departments use to procure viral vaccines for immunization programs. Recent state and local activity under this code shows significant mismatch between the code's nominal scope and actual procurement: the one recent opportunity in the dataset is a sole source notice from the Mississippi State Department of Health for Yellow Fever Vaccine from Sanofi Pasteur, Inc., posted July 13, 2026, with objections due August 3, 2026. This is a notice of proposed sole source purchase rather than a competitive solicitation, meaning the health department has determined that only Sanofi Pasteur can supply the vaccine; any entity wishing to challenge the sole source designation must submit written objections with detailed evidence that alternative vendors exist. The Mississippi State Department of Health purchasing contact is Cynthia Brasher. The notice does not specify quantity, contract term, estimated value, or pricing.

The code shows limited recent activity and unclear demand signals. The single recent opportunity under this code addresses yellow fever vaccination rather than rubella and mumps virus vaccine, suggesting either misclassification in the state procurement system or a broader vaccine-procurement category that spans multiple pathogen types. No other state and local health departments, counties, or school districts appear in the recent opportunities block. The geographic spread is limited to Mississippi. Business development professionals pursuing state and local vaccine procurement should monitor whether this code continues to see activity under its stated scope or whether state health department procurement systems are routing vaccine buys through different UNSPSC categories or broader vaccine family codes.